Surgeon uses Anika's injectable bone repair therapy — 4 insights

Written by Eric Oliver | August 13, 2019 | Print  |

John Tierney, DO, used Anika Therapeutics' injectable hyaluronic acid-based bone repair product in a patient.

What you should know:

1. Anika designed the product to treat bone voids and other bone defects caused by trauma or age-related degeneration.

2. Dr. Tierney, an orthopedic surgeon at Boston-based New England Baptist Hospital, spoke highly of the therapy, praising its ease of use.

3. Anika designed the therapy to meet the needs of the 900,000 people who have bone voids or bone defects of the knee.

4. Anika will launch the therapy commercially in September.

More articles on biologics: 
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure
The big trends, issues in spine shaping practices today

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months